GlassScriptPhysician profile
Sheena Plowden
NPI 1538440334
$1,609.88
in general payments reported to CMS, 2019-2025
21 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,145 · 2022: $21.92 · 2023: $33.97 · 2024: $125 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $207.88 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $190.74 | 2021 | |
| Novo Nordisk INC | $163.22 | 2021 | |
| Madrigal Pharmaceuticals | $145.61 | 2025 | Rezdiffra |
| Amgen INC. | $121.91 | 2021-2024 | Prolia, Evenity, Krystexxa |
| Janssen Biotech, INC. | $120.03 | 2025 | Tremfya |
| Janssen Pharmaceuticals, INC | $94.43 | 2021 | |
| Amarin Pharma, INC. | $93.34 | 2021 | |
| Esperion Therapeutics, INC. | $75.58 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.56 | 2021 | |
| Lilly USA, LLC | $52.85 | 2021 | |
| Genentech USA, INC. | $50.07 | 2021 | |
| Glaxosmithkline, LLC. | $43.68 | 2021-2025 | Shingrix |
| Kowa Pharmaceuticals America, INC. | $29.64 | 2021 | |
| Novartis Pharmaceuticals Corporation | $27.10 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $26.10 | 2021 | |
| Merck Sharp & Dohme LLC | $25.86 | 2021 | |
| Pfizer INC. | $21.92 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.28 | 2021 | |
| Eisai INC. | $16.94 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheena Plowden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.